Determinants of the Pathological Features of Renal Adverse Effects Due to Vascular Endothelial Growth Factor Signaling Inhibition

Intern Med. 2022 Dec 1;61(23):3469-3471. doi: 10.2169/internalmedicine.0044-22. Epub 2022 May 14.

Author

Kiyoshi Mori^{1

2}

Affiliations

¹ Graduate School of Public Health, Shizuoka Graduate University of Public Health, Japan.
² Department of Nephrology and Kidney Research, Shizuoka General Hospital, Japan.

No abstract available

Keywords: cancer; collapsing glomerulopathy; glomerular microangiopathy; proteinuria; vascular endothelial growth factor.

MeSH terms

Glomerulosclerosis, Focal Segmental*
Humans
Kidney / pathology
Proteinuria / pathology
Vascular Endothelial Growth Factor A*

Substances

Vascular Endothelial Growth Factor A